The Global Ultrasound Institute (GUSI) is proud to announce the launch of the GUSI Fellowships Platform, an innovative online platform designed to empower learners around the world to achieve confidence and competency in point-of-care ultrasound (POCUS).
Global Ultrasound Institute (GUSI), the leading provider of point-of-care ultrasound (POCUS) education and training, is thrilled to announce the launch of its latest innovation, POCUS Essentials Plus Simulation.
Dr. Bruce Greyson is a distinguished professor emeritus of psychiatry and behavioral sciences at the University of Virginia. With an academic journey spanning over half a century, Dr. Greyson has dedicated a significant portion of his career to the study of near-death experiences (NDEs).
Florida State University’s College of Nursing has launched the nation’s first master’s degree combining artificial intelligence and health care with a curriculum that will expand digital health initiatives into clinical benefits for patients through more advanced, efficient and personalized care.
A mother and daughter survive complex brain aneurysms, including the daughter's ruptured aneurysm, after receiving care from neurosurgeon Rafael De Oliveira Sillero, M.D., and his partners at UT Southwestern Medical Center.
Friday, September 20, 2024, CLEVELAND: A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications. The paper was published in Annals of Surgery.
Denise Côté-Arsenault, Ph.D., an internationally recognized expert in pregnancy loss at Saint Louis University’s Trudy Busch Valentine School of Nursing, will work with a group of Ph.D. midwives on their research on parent experiences with pregnancy and birth with life-limiting fetal diagnosis.
Today, the FDA announced the first approved treatment for Niemann-Pick Type C (NPC) disease: an oral medication named Miplyffa (arimoclomol). Sean Kassen, director of the Ara Parseghian Medical Research Fund at the University of Notre Dame, said this represents the beginning of a new and hopeful era for NPC families.
$5 million gift from The Bob & Renee Parsons Foundation expands capacity for therapy, research, and training on psychedelic-assisted therapy
lec Pollard, Ph.D., professor emeritus of family and community medicine, recently received the International OCD Foundation (IOCDF)’s 2024 Outstanding Career Achievement Award. The IOCDF Awards recognize exceptional individuals and professionals for their dedicated efforts in advancing awareness, advocacy, and understanding of obsessive-compulsive disorder.
Dr. Jeremie Calais received two grants from Novartis totaling $4 million aimed at improving the effectiveness of the radiation-emitting targeted therapy 177-Lu-PSMA-617 for patients with metastatic castration-resistant prostate cancer (mCRPC), one of the most challenging forms of the disease.
An eight-year project aims to uncover the complex web of interacting factors that drive oral health inequity, which in turn affects many other serious health conditions.
Cedars-Sinai has announced a partnership with the LA28 Olympic and Paralympic Games to serve as the Official Medical Provider for the 2028 Games, providing the highest-quality care for athletes, coaches, team personnel and visitors who travel across the world for the competitions in Los Angeles.
Cedars-Sinai ha anunciado hoy su asociación con los Juegos Olímpicos y Paralímpicos de LA28 para fungir como proveedor médico oficial de los Juegos de 2028, proporcionando atención de la más alta calidad a los atletas, entrenadores, personal del equipo y visitantes que viajen de todo el mundo con motivo de las competencias en Los Ángeles.
A survey of Syrian refugees living in Jordan reveals that higher levels of self-compassion are associated with better mental health. The findings suggest that interventions teaching self-compassion have the potential to boost the mental health of displaced individuals.
UCLA investigators have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to work for each individual patient.
Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that Health Canada has approved the CardioFlux Magnetocardiograph with a license for use by physicians to aid in the diagnosis of myocardial ischemia.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
